Colorectal Adenoma Clinical Trial
Official title:
Impact of 9-minute Withdrawal Time on Adenoma Miss Rate: A Multicenter, Prospective, Randomized Controlled Trial of Tandem Colonoscopy
Verified date | January 2022 |
Source | Changhai Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A mean withdrawal time of at least 6 minutes has been considered to be one of the critical quality criterions of colonoscopy. Recently, our group completed a multicenter randomized controlled trial, which proved that prolonging the withdrawal time to 9 minutes could significantly improve the adenoma detection rate of colonoscopists, especially for young colonoscopists and proximal colon. However, it has some limitations in included participates (mixed indications for colonoscopy) and cannot illustrate the impact of withdrawal time on adenoma miss rate in a parallel randomized design. It is necessary to include tandem colonoscopy and adopt strict criteria of the screening population to confirm the effect of the 9-minute withdrawal time on the adenoma miss rate. Therefore, the investigators plan to conduct a multicenter, randomized controlled trial of tandem colonoscopy to compare adenoma miss rate of 6-minute and 9-minute withdrawal in screening population.
Status | Completed |
Enrollment | 733 |
Est. completion date | December 5, 2021 |
Est. primary completion date | November 5, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility | Inclusion Criteria: - Patients whose age is between 40-75. - Patients who have indications for screening - Patients who have signed inform consent form. Exclusion Criteria: - Patients who have undergone colonic resection or polypectomy - Patients with alarming signs and symptoms of colorectal cancer: hematochezia, melena, anemia, weight loss, abdominal mass, positive digital rectal examination - Patients with abnormal blood coagulation or taking antiplatelets or anticoagulants within 7 days - Patients with inflammatory bowel diseases - Patients with a history of abdominal surgery, or highly suspected or confirmed colorectal cancers by radiographic and laboratory tests - Patients with hereditary colorectal cancer syndrome (including familial adenomatous polyposis). - Patients with pregnancy, severe chronic cardiopulmonary and renal disease. - Patients with failed cecal intubation - Patients with poor BPQ that necessitated a second bowel preparation - Patients with therapeutic colonoscopy for existing lesions - Patients refusing to participate or to provide informed consent |
Country | Name | City | State |
---|---|---|---|
China | Changhai Hospital, Second Military Medical University | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Changhai Hospital | Af?liated Hospital of North Sichuan Medical College, Heilongjiang provincial hospital, Leqing People's Hospital, No.85 Hospital, Changning, Shanghai, China, Qinghai People's Hospital, Seventh Medical Center of PLA Army General Hospital, Shanghai 8th People's Hospital, Shanxi Provincial People's Hospital, Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine, The First Affiliated Hospital of Dalian Medical University, The First Affiliated Hospital of the Medical College, Shihezi University, The General Hospital of Eastern Theater Command, The Second Hospital of Hebei Medical University, Yantaishan Hospital of Yantai City, Yantai, China, Zhejiang University |
China,
Zhao S, Wang S, Pan P, Xia T, Chang X, Yang X, Guo L, Meng Q, Yang F, Qian W, Xu Z, Wang Y, Wang Z, Gu L, Wang R, Jia F, Yao J, Li Z, Bai Y. Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. Gastroenterology. 2019 May;156(6):1661-1674.e11. doi: 10.1053/j.gastro.2019.01.260. Epub 2019 Feb 6. — View Citation
Zhao S, Yang X, Wang S, Meng Q, Wang R, Bo L, Chang X, Pan P, Xia T, Yang F, Yao J, Zheng J, Sheng J, Zhao X, Tang S, Wang Y, Wang Y, Gong A, Chen W, Shen J, Zhu X, Wang S, Yan C, Yang Y, Zhu Y, Ma RJ, Wang R, Ma Y, Li Z, Bai Y. Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e168-e181. doi: 10.1016/j.cgh.2020.11.019. Epub 2020 Nov 19. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | adenoma miss rate(AMR) | Adenomas detected in the second-pass examination were defined as missed adenomas; the AMR was defined as follows: number of adenomas detected in the second-pass examination/total number of adenomas detected in the two pass. | 60 minutes | |
Secondary | advanced adenoma miss rate(AAMR) | AAMR is the number of advanced adenomas detected in the second-pass examination/total number of advanced adenomas detected in the two pass. | 60 minutes | |
Secondary | adenoma detection rate(ADR) | ADR is the number of patients with at least one adenoma, divided by the total number of patients. | 60 minutes | |
Secondary | adenomas per colonoscopy(APC) | APC was calculated as the number of adenomas detected during colonoscopy withdraw divided by the number of colonoscopies. | 60 minutes | |
Secondary | patient-level AMR(pAMR) | the number of participants with adenomas detected only during the second-pass colonoscopy divided by the total number of participants with adenomas detected during the tandem colonoscopy | 60 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04192565 -
A Prospective Investigation of the ColubrisMX ELS System
|
N/A | |
Completed |
NCT04516785 -
Reducing Colonoscopies in Patients Without Significant Bowel Disease
|
||
Recruiting |
NCT05381792 -
Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia
|
||
Withdrawn |
NCT05606081 -
Predicting Risk for Post-polypectomy Colorectal Cancer
|
N/A | |
Recruiting |
NCT05576506 -
Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy
|
||
Active, not recruiting |
NCT03796884 -
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
|
Phase 2 | |
Completed |
NCT05508503 -
A Study on a Blood-based Dual-target Test for CRC Detection
|
||
Recruiting |
NCT02935049 -
Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique
|
N/A | |
Completed |
NCT05477836 -
Feasibility and Safety of MiWEndo-assisted Colonoscopy
|
N/A | |
Active, not recruiting |
NCT05740137 -
Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy
|
N/A | |
Active, not recruiting |
NCT05754229 -
Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy
|
N/A | |
Completed |
NCT03234725 -
Analysis of New Endoscopic Features and Variable Stiffness in Colonoscopy: Prospective Randomised Trial
|
||
Completed |
NCT05913453 -
Technical Failure During Colorectal Endoscopic Full Thickness Resection (EFTR): The "Through Thick and Thin" Study
|
||
Recruiting |
NCT05261932 -
Research on Endoscopic Precision Biopsy.
|
||
Completed |
NCT02521727 -
To Investigate Risk of Colorectal Neoplasms in First-degree Relatives of Patients With Non-advanced Adenomas
|
||
Completed |
NCT02226185 -
Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence
|
Phase 2/Phase 3 | |
Completed |
NCT00298545 -
Effect of Vitamin D and Calcium on Genes in the Colon
|
Phase 1 | |
Completed |
NCT03268655 -
Ginger and Gut Microbiome (GINGER)
|
N/A | |
Active, not recruiting |
NCT04952129 -
Optimal Selenium for Bowel Polyps (OSCAR)
|
Phase 1 | |
Recruiting |
NCT04444908 -
Development and Validation of an Artificial Intelligence-assisted Strategy Selection System for Colonoscopy Cleaning
|